advertisement

---

Kook MS 6

Showing records 1 to 6 | Display all abstracts from Kook MS

98956 Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease
Park SW
Pharmaceuticals (Basel, Switzerland) 2022; 15:

---

98937 Optic Disc Hemorrhage Is Not Associated with Global Choroidal Vessel Loss, but Is Associated with Localized Choroidal Vessel Loss in Glaucoma
Lee A; Shin JW
Journal of clinical medicine 2022; 11:

---

98956 Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease
Lee J
Pharmaceuticals (Basel, Switzerland) 2022; 15:

---

98937 Optic Disc Hemorrhage Is Not Associated with Global Choroidal Vessel Loss, but Is Associated with Localized Choroidal Vessel Loss in Glaucoma
Lee JY
Journal of clinical medicine 2022; 11:

---

98956 Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease
Kook MS
Pharmaceuticals (Basel, Switzerland) 2022; 15:

---

98937 Optic Disc Hemorrhage Is Not Associated with Global Choroidal Vessel Loss, but Is Associated with Localized Choroidal Vessel Loss in Glaucoma
Baek MS; Kook MS
Journal of clinical medicine 2022; 11:

---